Navigation Links
ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
Date:12/17/2009

logy and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to enter into transactions around its product candidates, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2008 and Anadys' Form 10-Q for the quarter ended September 30, 2009. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Pegasys® and Copegus® are registered trademarks of Hoffman-La Roche Inc.

SOURCE Anadys Pharmaceuticals, Inc.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
11. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  EP Global Communications, Inc. (Public OTC: EPGL) announced ... the Company about discussing EPGL,s electronic contact lens ... August 3, 2015.  Novartis CEO Joe Jimenez ... coming electronic contact lens market could be worth ... several years.  Novartis partnered with Google in 2014 ...
(Date:7/30/2015)... 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the second quarter ending June 30, 2015. ... across the organization.  We are excited to be near ... trial ever conducted with topline results expected in the ... Officer, PTC Therapeutics, Inc. "Translarna is now commercially available ...
(Date:7/30/2015)... PARSIPPANY, N.J. , July 30, 2015  Growth ... Rx-to-OTC switches as they bring former prescription users to ... environment, Kline forecasts robust Rx-to-OTC switch activity ... OTC categories emerging along with many new brands entering ... switches occur over the next five years (even those ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... 2011 Environmental testing and monitoring programs ... Companies must understand industrial sterilization and contamination control procedures ... budget. In attempting to meet regulatory ... the European Pharmacopoeia, the greatest challenge for medical device ...
... AUGUSTINE, Fla., Aug. 10, 2011 Flagler Hospital ... selected the Sunrise Enterprise ™ suite of clinical ...  In addition to implementing Sunrise within the hospital, Flagler ... Record (EHR) and practice management solution for its ...
Cached Medicine Technology:"Environmental Monitoring and Certification in Controlled Environments: Meeting Regulations and Achieving Effective Microbial Control for Pharmaceutical and Medical Device Manufacturers" - New White Paper from Microtest Laboratories 2Flagler Hospital Selects the Sunrise Enterprise Acute Care Solution From Allscripts 2Flagler Hospital Selects the Sunrise Enterprise Acute Care Solution From Allscripts 3Flagler Hospital Selects the Sunrise Enterprise Acute Care Solution From Allscripts 4Flagler Hospital Selects the Sunrise Enterprise Acute Care Solution From Allscripts 5Flagler Hospital Selects the Sunrise Enterprise Acute Care Solution From Allscripts 6
(Date:7/31/2015)... ... 31, 2015 , ... Successful Import/Export Programs:, Former FDA Expert ... Having FDA-regulated products held at ports costs time, money and the competitive edge. ... even destruction — of products, an FDA insider shows manufacturers how to implement ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The alarm was ringing. Hugh Chatfield, survivor of ... of the window, he recalled that his equipment was set up to depict the newly ... jumped out of bed. , The photo speaks for itself. Chatfield is also a highly ...
(Date:7/31/2015)... BC (PRWEB) , ... July 31, 2015 , ... ... has recently published a blog post that encourages the understanding and treatment of ... many people opt for in-home remedies. This can be dangerous if the condition ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... in Birmingham. The U.S. Women's National Soccer Team will face the Australia Women's National ... Thursday, September 17th at Ford Field in Detroit and the second match will occur ...
(Date:7/31/2015)... N.Y. (PRWEB) , ... July 31, 2015 , ... ... is proud to announce that their latest designer handbag line will be named ... become an Internet sensation as the first globally recognized model with Down syndrome, ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3
... has identified factors that predict the ability of a ... arthroscopy surgery. The study by Hospital for Special Surgery ... Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San ... that ballet dancers were significantly less likely to be ...
... is associated with negative outcomes for the mother, including increased ... length of stay in the hospital, and does not provide ... deliveries continues to climb, it is important for physicians and ... The new findings, published in the February issue of ...
... diabetes and CKD have an increased risk of adverse ... diabetes and overt nephropathy develop End-Stage Renal Disease (ESRD) ... of death and ESRD may confound the estimates of ... at the University of Helsinki, University Hospital of Helsinki ...
... Behen HealthDay Reporter , THURSDAY, Feb. 17 (HealthDay ... remembering, learning and processing information in warm weather than in ... Kessler Foundation in West Orange, N.J., found that patients with ... or cognitive functioning, on cooler days than they did at ...
... , THURSDAY, Feb. 17 (HealthDay News) -- People who ... times increased risk of developing Parkinson,s disease, a new ... Parkinson,s disease and 358 people without the nervous system ... Farming and Movement Evaluation Study involving licensed pesticide applicators ...
... WASHINGTON "Go Viral to Improve Health: IOM-NAE Health ... of Medicine and National Academy of Engineering to promote ... to spur interest in harnessing new technologies and data ... on university and college students studying engineering, computer science, ...
Cached Medicine News:Health News:Study explores ability of professional dancers to return to their career after hip arthroscopy 2Health News:Study explores ability of professional dancers to return to their career after hip arthroscopy 3Health News:Scheduled deliveries raise risks for mothers, do not benefit newborns 2Health News:Scheduled deliveries raise risks for mothers, do not benefit newborns 3Health News:Competing risks analysis highlights new targets in preventing ESRD and death of diabetics 2Health News:Warm Weather May Cloud Thinking in MS Patients 2Health News:Warm Weather May Cloud Thinking in MS Patients 3Health News:2 Pesticides Linked to Parkinson's in Study 2Health News:IOM and NAE launch collegiate challenge aimed at solving health problems 2